Cargando…
Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects
Mesenchymal stem cells (MSCs) possess immunomodulatory properties that have therapeutic potential for the treatment of inflammatory diseases. This study investigates the effects of direct MSC administration on asthmatic airways. Umbilical cord MSCs (ucMSCs) were intratracheally administered to six-w...
Autores principales: | Mo, Yosep, Kang, Hanbit, Bang, Ji-Young, Shin, Jae Woo, Kim, Hye Young, Cho, Sang-Heon, Kang, Hye-Ryun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276742/ https://www.ncbi.nlm.nih.gov/pubmed/35821386 http://dx.doi.org/10.1038/s41598-022-14846-y |
Ejemplares similares
-
Intravenous Mesenchymal Stem Cell Administration Modulates Monocytes/Macrophages and Ameliorates Asthmatic Airway Inflammation in a Murine Asthma Model
por: Mo, Yosep, et al.
Publicado: (2022) -
Mesenchymal stem cells exert their anti-asthmatic effects through macrophage modulation in a murine chronic asthma model
por: Kim, Ruth Lee, et al.
Publicado: (2022) -
Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis
por: Choi, Sun Mi, et al.
Publicado: (2023) -
Mesenchymal Stem Cells Attenuate Asthmatic Inflammation and Airway Remodeling by Modulating Macrophages/Monocytes in the IL-13-Overexpressing Mouse Model
por: Mo, Yosep, et al.
Publicado: (2022) -
CYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics
por: Yim, Eun-Young, et al.
Publicado: (2013)